Amanote Research
Register
Sign In
Discovery of a Potent Dual Inhibitor of Wild-Type and Mutant Respiratory Syncytial Virus Fusion Proteins
doi 10.1021/acsmedchemlett.0c00008.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Discovery of Piperazinylquinoline Derivatives as Novel Respiratory Syncytial Virus Fusion Inhibitors
Chimeric Bovine Respiratory Syncytial Virus With Attachment and Fusion Glycoproteins Replaced by Bovine Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase and Fusion Proteins
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Neutralizing Epitopes on the Respiratory Syncytial Virus Fusion Glycoprotein
Current Opinion in Virology
Virology
Structure Based Discovery of Clomifene as a Potent Inhibitor of Cancer-Associated Mutant IDH1
Oncotarget
Oncology
Respiratory Syncytial Virus
JAMA - Journal of the American Medical Association
Medicine
Recombinant Sendai Viruses Expressing Fusion Proteins With Two Furin Cleavage Sites Mimic the Syncytial and Receptor-Independent Infection Properties of Respiratory Syncytial Virus
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Cellular Immune Correlates Preventing Disease Against Respiratory Syncytial Virus by Vaccination With Virus-Like Nanoparticles Carrying Fusion Proteins
Journal of Biomedical Nanotechnology
Materials Science
Nanoscience
Pharmaceutical Science
Medicine
Bioengineering
Nanotechnology
Biomedical Engineering
Respiratory Syncytial Virus
Discovery of Novel Dual Inhibitors of the Wild-Type and the Most Prevalent Drug-Resistant Mutant, S31N, of the M2 Proton Channel From Influenza a Virus
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
